Steris (STE) FCF Payout Ratio Growth (3y) (2021 - 2025)
Steris (STE) FCF Payout Ratio Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.81% |
| Sep 30, 2025 | -48.34% |
| Jun 30, 2025 | -22.60% |
| Mar 31, 2025 | 26.04% |
| Dec 31, 2024 | -54.00% |
| Sep 30, 2024 | -6.00% |
| Jun 30, 2024 | -31.91% |
| Mar 31, 2024 | 115.61% |
| Dec 31, 2023 | 39.21% |
| Sep 30, 2023 | 41.49% |
| Jun 30, 2023 | -22.66% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | 93.70% |
| Jun 30, 2022 | -8.46% |
| Mar 31, 2022 | -14.00% |
| Dec 31, 2021 | -8.63% |
| Sep 30, 2021 | 13.00% |
| Jun 30, 2021 | 32.28% |